The Discounted Cash Flow (DCF) valuation of Royalty Pharma PLC (RPRX) is 65.02 USD. With the latest stock price at 58.41 USD, the upside of Royalty Pharma PLC based on DCF is 11.3%.
Based on the latest price of 58.41 USD and our DCF valuation, Royalty Pharma PLC (RPRX) is a buy. buying RPRX stocks now will result in a potential gain of 11.3%.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 7.4% | 6.3% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 32.19 - 306.53 | 65.02 |
| Upside | -44.9% - 424.8% | 11.3% |